Drug Policy in France: From Criminalization to Risk Reduction
Michel KOKOREFF
Is France different from
everyone else? Our attitude to drugs is paradoxical. It is true that drug
policies in France have taken a new approach since the mid 1990s[1],
an approach prompted by a new awareness of public health problems related to the
consumption of illegal drugs, as well as legal drugs like tobacco and alcohol;
by the fact that drug abuse can simply not be eliminated; and by pressure from
surrounding countries, since France could no longer deal with the issue alone[2]. AIDS was a new factor,
though it entered the equation late in the day. The attitudes of many
stakeholders have altered. Some police officers still believe that cannabis use
should be decriminalized, an approach unthinkable a few years ago, and
magistrates are increasingly reluctant to put simple users in jail. Drug-related
care personnel are no longer hostile towards substitution, as they had been for
a long time (Bergeron, 1999). New parties, such as locally-elected politicians,
family physicians and even users themselves, are also becoming involved. These
changes have came about as the social sciences research environment was
reorganized and as an increased number of empirical studies revealed more
information about consumers of illegal products, parallel markets and public
opinion.
Yet nothing has really
changed. The 1970 drug act still underpins French policy on the war against
drugs and drug abuse; it is still predominantly influenced by repressive
reasoning legitimized by a prohibitionist model, at the expense of health and
social well-being[3].
The unrelenting stance of the chief political actor, the State, is obvious, as
is the absence of any political response to repeating demands for legislative
amendments and any decriminalisation of soft drugs. The more security-minded
constantly argue that there is a link between “drugs” and “delinquency”,
and focus on events in the “suburbs” and the behaviour of young immigrants.
On the whole, even though we hear less moralizing from official sources, it is
the pragmatic approach — the application of criminal law and health
requirements — that prevails over less clear-cut approaches like crime
reduction and prevention.
In this context, the
problem of determining criminal penalties for drug offences in France is
twofold. In establishing any kind of a priority categories, we should be
cautious of taking a “criminalization policy” for granted. The strategy of
criminalizing not only trafficking but also private and public use is not really
practicable, and leads to adjustments in the legislation for different local
contexts. This has prompted the generatio9n of an impressive number of plans,
directives, circulars and other texts[4]
designed to harmonize judicial practices and to apply criminal law to new
situations[5].
This is also entailed a review of the legitimacy of the drug act and recurring
debates about amending it, in line with the initiatives taken by other EU
countries.
Both official reports and
field investigations reveal disparities among jurisdictions, though such
disparities are obviously not specific to drug-related cases and appear in other
cases as well. We may wonder whether their result is criminalization policies
that apply in a local context only. Yet diversity of judicial practices as
regards both prosecution and conviction need not necessarily imply that policies
in their true sense — that is, actions guided by choices and priorities —
really exist. The practices that largely guide decision-making arise from
institutional approaches and complex interactions among stakeholders extending
far beyond the scope of criminal law. A study of penal trends based on
quantitative research has made it easier to understand the diversity (Aubusson
de Cavarlay, 1987, 1997; Barré, 1994). Another avenue for research is a
territorial approach to the penal treatment of ODA cases, which compares current
practices in various jurisdictions with a more qualitative approach (Duprez,
Kokoreff, Weinberger, 1996, 2001).
Data gathering present a
further problem: any study that goes beyond generalities on law and justice
requires a critical analysis of penal practices, which in its turn
requires access to data on the activities of various jurisdictions. Such
data are largely unavailable. When the 1970 drug act came into force, the courts
were asked to perform an assessment role so that more knowledge about the
sentencing applied to drug users overall could be gained. The data were gathered
between 1971 and 1981, but because the resulting statistics were not accurate,
application of the drug act could not be studied satisfactorily. This explains
the total lack of data on application of the 1970 drug act between 1984 and
1992. Since 1992, only prescribed therapeutic injunctions have been counted by
the courts, and there is no indication as to how such measures were followed up.
(Aubusson de Cavarlay, 1997, 9-10) Even when the data are available, it is not
always easy to determine what they measure. Do they measure decisions, cases or
persons? I believe that a study of legal files supplemented by interviews is a
useful and reliable method. Likewise, we could say a great deal about the role
of the police, the use of statistics on arrests for use and trafficking, and the
biases that they represent. In fact,
we know that the data do not reflect actual illegal activity as much as they
reflect actual police activity. They constitute an indirect indicator of police
action, a factor that must be borne in mind when using them.
The ambiguous French drug
regulation model results in differential practices across the country, and does
noting to conceal the twofold issue of the drug act’s equity and efficiency (Henrion,
1995). To avoid hasty generalizations, there must be a new approach on two
fronts: first, we must focus not on criminal law as such but rather on how it is
applied locally; second, we must focus not on official policies at the national
level but on how institutions actually apply them in practice.
1.
Ambiguities in the drug act
But first, I would
like to come back to the ambiguities in the 1970 drug act. Alain Ehrenberg
clearly demonstrated the types of political culture implicit in the drug act, as
well as the issues raised by criminal interdiction. Within the perception of the
French tradition where the State shapes social order, he writes “The drug
users is someone who must be reminded that he is living in society before we can
prevent him from destroying himself” (Ehrenberg, 1996). But the drug act also
reveals the ambiguities in the French model that generate an ongoing tension
between criminal and medical laws, playing on the confusion between a public
problem and a psychopathological problem, to justify criminalization more
effectively. The 1970 drug act
resulted from both a normative (De Munck, 1996) and political (Bernat de Célis,
1992) compromise between a number of reference models. Basically, it holds two
concepts of the drug user, the delinquent and the patient. There is the
repressive aspect characterized by penalizing private use — a provision not in
the previous 1916 drug act — a prosecution procedure overriding common law,
severe sentences for traffickers, which were re-enforced with the adoption of
the new Criminal Code in 1994; the Code made organized trafficking in gangs
punishable by a life sentence[6].
But there is also a medical aspect, which promotes treatment for “drug
abusers”. Due to pressure from psychiatrists, the legislation provides an
option for voluntarily undergoing medical treatment, anonymously and free of
charge[7].
The three basic principles of the French care model offered a way of providing
refuges in drop-in and health institutions, and of protecting those areas from
police action and social control (Morel, 1997, 84).
Injunctions to undergo
treatment
The compromise is illustrated by the therapeutic injunction, an
unprecedented measure aimed at inducing users to undergo treatment. The
injunction was a decision of the Republic’s Solicitor General. Under it, users
who agreed to undergo treatment had the charges against them dropped; if they
did not agree, they were prosecuted, especially if they were for repeat
offenders. The injunction was therefore subject to legal criteria alone.
The injunction and similar
measures were viewed with extreme wariness by many parties involved in drug
abuse. They failed to see how users could be forced to undergo treatment.
Indeed, such measures did not become genuinely efficient until the mid 1980s,
and their application led to an often criticized imbalance between the penal
approach and the health-oriented approach[8].
This becomes obvious when we compare the number of arrests for use of illegal
substances (over 70,000 in 1998, out of a total of 90,000) with the number of
therapeutic injunctions handed down (slightly over 8,000) and implemented
(nearly 4,000) (Simmat-Durand, 1999).
The assessment of Setbon
(1998) shows how unequally the injunction is applied in various jurisdictions
and how its results are almost impossible to assess. The author shows the
limited effectiveness and efficiency of therapeutic injunctions. Encouragement
to undergo treatment is applied inconsistently, “without impact and without
any equitable distribution”. Yet it is unlikely that any substantial group of
drug users subject to the injunction could in fact receive the treatment they
require. “With the sequential, hierarchical structure of the therapeutic
injunction process, co‑ordination between the problem (the drug user’s
condition), the drug user’s chances of becoming eligible for a therapeutic
injunction, the nature of the care provided and the social health objectives are
left entirely up to chance.” (Setbon, 1998, 132). As such, the issue is more
to determine whether such measures are actually useful than it is to determine
the legitimacy of the drug act, though that is where public debate in France is
focused.
In fact, a therapeutic
injunction is a vague measure allowing for differential application. It is meant
to prevent trafficking (by trying to reduce consumption, we try to stop the user
from becoming a dealer to fund his own habit), to prevent delinquency (by trying
to reduce consumption, so as to reduce offences by users), to prevent repeat
offences (which are still tolerated when part of a healing process) and to avoid
overcrowding prisons (the penal system contains many drug abusers sentenced for
ODA and “hidden” drug users prosecuted for other offences). Given these
divergent goals, we clearly see how a social and penal approach has been
superimposed over the health care approach.
Repressing
use: the cannabis police
Another
example of the ambiguous way in which the drug issue is dealt with in France is
the existing disparity between the debate on criminalization and current police
procedures. The issue comes up regularly, raising many fears rooted in the
existing confusion surrounding decriminalization and legalization. Recent polls
indicate that opinions are changing rapidly (Beck, Peretti-Watel, 1999). With
respect to the prohibition against consuming illegal substances, opinions are
divided: 52% of people surveyed believe that the prohibition against cannabis is
ineffective; that number is only 48% for heroin. Overall, the people surveyed
were not in favour of legalizing cannabis. However, 30% of people did believe
that access to cannabis should be regulated.
In
spite of those changes, measures to repress use remain strong (see table below),
an approach clearly illustrated by the statistics on police activities. Police
action involving young people has increased considerably, from 24,588
cannabis-related incidents in 1993 to 73,661 incidents in 2000. Heroin-related
police activity has dropped, from 13,299 incidents in 1995 to 4,831 incidents in
2000, while activity related to crack and cocaine use, though much less, has
almost doubled, from 997 incidents in 1995 to 1,651 incidents in 2000). The
police is essentially a cannabis police.
Police activity by product and ODA category between
1985 and 2000.
Substance |
ODA
category |
1985 |
1990 |
1995 |
1998 |
1999 |
2000 |
Cannabis |
Use Use+resale Trafficking TOTAL |
11 896 2 093 1 251 15 240 |
17 736 2 452 1 926 22 144 |
36 325 5 386 2 986 44 697 |
64 479 8 342 2 920 75 741 |
70 802 8 002 2 948 81 752 |
73
661 8 688 3 625 85 974 |
Heroin |
Use Use+resale Trafficking TOTAL |
8 427 2 266 2 530 13 223 |
6 522 1 560 2 478 10 560 |
13
299 4 057 3 329 20 685 |
6 019 1 450 1356 8 825 |
4 911 1 230 1 126 7 267 |
4 831 1 002 1 228 7 061 |
Cocaine |
Use Use+resale Trafficking TOTAL |
254 130 228 612 |
388 127 414 930 |
651
196
376 1 223 |
1 925
457
789 3 171 |
2
087
497 1 003 3 587 |
1 944
379 1 088 3 411 |
Crack |
Use Use+resale Trafficking TOTAL |
|
|
346
181
73
600 |
588
211
183
982 |
636
177
185
998 |
707
162
200 1 069 |
Ecstasy |
Use Use+resale Trafficking TOTAL |
|
24
8 13 45 |
844
278
276 1 398 |
766
220
199 1 185 |
711
204
169 1 084 |
1
432
489
312 2 233 |
TOTAL |
Use Use+resale Trafficking TOTAL |
21 133 4 571 4 046 29 750 |
24 856 4 159 5 198 34 213 |
52 112 10 213 7 107 69 432 |
74 633 10 874 5 541 91 048 |
80 037 10 367 5 506 95 910 |
83
385 10 954 6 531 100 870 |
Source:
OEDT 2001
In
the above trends, should we be seeing a police strategy of anticipating less
active of heroin use because substitute products are being provided? Have the
results effected cannabis use in other ways? This is a hypothesis we should not
exclude. We also note the disparity between activity related to narcotic use and
activity related to narcotic trafficking. Does that indicate that traffickers
are becoming more professional (Kokoreff, 2000)? These statistics of course have
their limitations, tending to under-estimate the development of local
trafficking. “Police forces in Great Britain, Germany and Italy have set up
trafficking observation tools. Those tools do not exist in France.”[9] We
might expect police forces to shift their focus and concentrate on cannabis
trafficking rather than cannabis use. If in the field some police officers
denounce the repressive activities engaged in against users, either because of
their convictions or because police forces are simply overloaded, the official
line remains the same: police officers apply the law, and the growth in police
activity related to cannabis use is justified by the increase in cannabis use
among young people and by civil disorder in the cities.
Along
the same lines, a link is made between substance abuse and delinquency. Among
the unsubstantiated statistics around for some 20 years, we find one to the
effect that one out of two offenders is a delinquent. This is one way of
legitimizing repressive action against drug users, who, as Setbon (1995) showed,
is far from being clearly demonstrated. However, Barré’s work shows how
complex that link truly is, and how there is nothing mechanical about. In a
recent article, Barré states that she has discovered the following in her
investigations: a/ delinquents use drugs infrequently; b/ however, drug-using
delinquents offend more often than non-users; on the whole, however, offences
attributable to drug users, particularly users of hard drugs, is far below the
statistics occasionally attributed to them. (Barré, 2001, 4)
Co-existence of repressive and tolerant practices
A
third remarkable manifestation of the ambiguity is how, at the local level,
repressive practices co-exist with emerging risk-reduction practices. An addict
can obtain a clean syringe from a publicly funded facility, but be arrested as
he gets off the bus or leaves the facility for possession a narcotic. This
somewhat paradoxical state of affairs demonstrates the remarkable, and even
brutal, changes that have taken place in recent years. The first public health
stand was taken in 1987, by suspending a 1972 decree requiring identification to
buy a syringe in a pharmacy. Syringe exchange and steribox sale programs were
developed in the early 1990s[10].
the Henrion Report[11]
appeared in February 1995, recommending the rapid development of a
risk-reduction policy. The report was supported by a range of humanitarian and
church authorities, including the Comité Consultatif National d’Ethique
(1994), the Commission sociale de l’Episcopat (1997), and the Human Rights
League (1996). The media commented widely, ushering in public debate on the risk
reduction through the actions of a variety of humanitarian and militant
associations. High doses of methadone and buprenorphin (Subutex®) were
authorized for marketing in 1995. Subutex® was distributed by general
practitioners and with few administrative barriers, so treatment with it
developed rapidly, even too rapidly (Lert et al., 1998), while methadone
distribution, permitted only in specialized centres, remained much less
widespread (Morel, 2001). According to Lert (2000), the number of patients under
methadone treatment was estimated at approximately 3,500 in July 1999, while
64,000 patients were on Subutex®[12].
In the field, professionals
denounced the police pressures undermining their efforts to implement
risk-prevention procedures and facilities. Syringe exchange and AIDS prevention
buses were set up near dealing sites to facilitate access to more marginalized
users. Though they often attracted the dealers’ ire, these first-line teams
negotiated with police to limit arrests. At the local level, therefore, the
teams managed to co-exist with police forces. The Association française pour la
réduction des risques goes even further, by stigmatizing the inconsistencies in
actual supply patterns, noting that it was obviously absurd to distribute
syringes and then prohibit their use. In Switzerland and Germany, there are
injection facilities making it possible to manage drug use and guaranteeing the
hygienic and safe conditions required for risk-free injection. With such
facilities, users have no need to use public spaces or building stairways.[13]
2.
Differential application
The law, which is founded
on the principle of universality, is supposed to apply to everyone and
everything in the same manner. It must apply equally in Marseille, Paris and
Brest, as well as in Strasbourg and Lille. During interviews, the universality
principle was liberally quoted by magistrates in defining their activities:
applying the law, complying with procedures, and working towards the
manifestation of truth. On that basis, at least at the outset, they tend to
focus less on the local implications of their actions and on actual jurisdiction
in which they operate.
Yet differential
application of the criminal law has been an established fact for over ten years,
as a number of studies have shown[14].
Such differential application, which emerged in so many cases during the 1990s,
is now firmly established. A recent report on criminal policy submitted to the
Guard of the Seal in 1999 confirms this. Prosecution thresholds are defined on
the basis of substance quantities seized and the substances themselves, as well
as on jurisdictions[15].
Other activities were also designed for substance-abusing offenders, while
post-sentencing measures were adapted for substance abusers in a small number of
jurisdictions.
One way to summarize the
arresting process in the area of drug use and trafficking is this: the
principles are uniform, but their application is not. Institutional impacts are
closely related to location-specific criteria. Thus, Customs authorities might
play an important or less important role, depending on nearness of the location
in question to the border and the means at their disposal: financial constraints
may limit arrests, while drugs can be considered as goods that generate taxes.
Police arrests are directly associated with the services available, for example
the amount of drugs involved in the trafficking and the availability of a nearby
regional police detective force. The data collected are also used by prosecutors
in determining their approach. In some courts, like Lille, individuals are not
prosecuted for use, except if large amounts or offenders known to the police are
involved. Though it is not provided for in the legislation, magistrates do make
a distinction between hard drugs and soft drugs.
On the basis of a comparative study of criminal policies implemented in three jurisdictions (Nanterre in the Hauts-de-Seine Region, Bobigny in the Seine Saint-Denis Region, and Lille in the North), there are three spheres in which we find non-uniform application: the police forces which intervene, the way courts are organized, and the procedures applied. By way of background information (see table), it is important to note that Hauts-de-Seine and Seine-Saint-Denis are two departments in the suburbs near Paris. The first is home to a world of contrasts: it is the second-richest department in France, but is also contains a number of neighbourhoods full of low-income social housing. The second is a typical example of a ‘red’ suburb, with a long-standing tradition of blue-collar workers hard hit by the social impact of the economic crisis. The Nord department, a border zone, is a former industrial basin which has also been affected by the decline in industrial activity. In these three examples, a sustainable parallel economy has developed. Drug dealing is just one aspect of this economy, which can be explained as a means of adapting to the upheavals in the labour market. Heroine, but increasingly cannabis and alcohol and mood-altering drugs, are becoming commonplace in this culture of self destructive behaviour: most drugs used are mood-altering drugs, as opposed to recreational products.
Comparison
of some indicators in Senie-Saint-Denis, Hauts-de-Seine, Nord and national-wide
|
Inhabitants |
Area
in sq. km |
Unemployment
rate (%) |
Crime
rate per 1000 inhabitants |
Number
of indictments due to ODAs (1998) |
National
|
58,722,674 |
543,965 |
10% |
60.72 |
83,797 |
Seine-Saint-Denis |
1,410,180 |
236 |
14.8% |
84.03 |
2,470 |
Haut-de-Seine |
1,418,780 |
176 |
9.9% |
69.05 |
2,416 |
Nord |
2,564,818 |
5,743 |
- |
71.73 |
8,657 |
Differences
in police service activities
A geographic approach
highlights the differences in public security service activities. On the basis
of police statistics recorded in 1994, it would appear that in
Seine-Saint-Denis, out of the 2,059 offences identified, more than 90% were
processed by public security services (commissariats, city police forces and the
police force drug squad) and just under 6% were processed by the departmental
police detective service. A very small number of cases were dealt with by the
gendarmerie (1.6%) and customs officials (1%). In Hauts-de-Seine, the
percentages are approximately the same. Between 1988 and 1994, 62% of procedures
were established by public security services, 22% by the gendarmerie and 16% by
the police detective service. In 1996, out of a total of 2,984 arrests, 80% were
processed by public security services; 12% by the gendarmerie, and 6.4% by the
police detective service.
However, in the Nord
department, where 5,605 offences were reported in 1994, nearly 45% of all cases
were opened by customs officials; 43% by public security services, 10% by the
gendarmerie and 2% by the police detective service. In trafficking alone, nearly
70% of all cases were initiated by customs officials.
An examination of cases
processed by the courts reflects a different picture for activities undertaken
by the various services involved. The Bobigny departmental court is an
especially interesting example: at the trial level, the number of cases
initiated by public security services is equivalent to that initiated by the
police detective service. This can be explained by the fact that the latter has
specialized in drug trafficking, while the public security services, whose role
is general in nature, recorded about 90% of the arrests. In those cases, the
vast majority of drug users were not officially charged.
There is evidence of
competition among the services, as well as of conflicting procedures. For
example, there is competition between an inflationist approach designed to
increase the number of arrests and seizures — sometimes prematurely — and
initiatives that aim to go beyond users and/or street dealers. The effect is
paradoxical, because the presence of public security units in the field
contributes to the entrenchment of illegal activities and can hinder the work of
police detectives.
Organization
of the courts
From an organizational perspective, some jurisdictions have
set up specialized sections to deal with the court cases resulting from offences
under the drug act. At the Bobigny departmental court the “drug cell” that
processes all cases involving trafficking and addictions (including therapeutic
injunctions) changed completely. Created in 1996, the new organization extended
its purview to include criminal cases and the fight against organized youth
crime. At the Nanterre departmental court, a reorganization of the various
sections resulted in a merger of the sections dealing with drugs and minors. The
creation of this section — which is unique in France, to the best of our
knowledge — is justified by the need to balance the judges’ workloads; it
stems from a worrisome increase in the involvement of young people in minor
cases of trafficking in neighbourhoods considered “sensitive”. At the same
time, the role of the financial sections has been developing with a view to
gaining a better understanding of operations drug money laundering operations
— a “money laundering culture”, in the words of a prosecutor. However,
there are still some shortcomings in this area. The Lille departmental court
does not have any specialized sections. This reality is a result of the added
pressure from increased caseloads and understaffing in comparison with other
jurisdictions.
Adjusting
procedures to meet local requirements
The
way procedures are used illustrates the differential practices in various
courts. Procedures are born if not out of the imagination of judges then out of
requirements in the jurisdictions to adapt to the local context. What has
changed are the requirements to open a file: in other words, the development of
a procedure to cover immediate appearances which, exceptionally, has become
commonplace. Another procedure has been implemented: summons by the police
detective or customs officer. This procedure has been used in a number of cases
involving offences under the drug act but also for other offences. It
represented up to 70% of the total number of cases in Lille in comparison with
50% in Nanterre. This also underscores the non-specific nature of drugs.
Criminalization
of drug-related cases is also an indicator of differential practices. The
procedure, which is extremely cumbersome as it involves long, costly hearings
and a meeting over several days of a special assize court made up of seven
members of the bench, varies immensely from one jurisdiction to another. In
Nanterre, five cases of importing cannabis by a gang were subject to a hearing.
In Bobigny, about a dozen criminal cases have been opened but they are often
referred to a correctional court. However, in Lille, no criminal cases were
opened although a number of them could have been made criminal cases.
The application of
therapeutic injunction measures as an alternative to criminal proceedings
enables us to quantify disparities in practices. Since the early 1990s, there
has been a significant increase in the number of therapeutic injunctions for
so-called “hard drug” users, whereas in the past this measure was not used
much. Unequal importance is also placed on this increase by the courts (see the
following table). Data from 1994 are revealing: while the number of therapeutic
injunctions ordered by the Bobigny departmental court was 1110; they represented
two-thirds of all cases for the Paris court (640), a mere one-third for the
Nanterre court (377) and one-seventh for the Lille court (161). Moreover, the
regular statistical follow-up is inconsistent: most jurisdictions have been
recording injunctions only since 1992, though some have been doing so since 1991
and a rare few since 1990. Starting in 1998, measures that have been
successfully completed (and that are filed under “no further action”) are
accounted for, but not measures ordered. Moreover, the scope of those measures
has been broadened to include reminders of the legislation and warnings issued
by the courts or their delegates. Tracking of these measures was inadequate
prior to 1998 and in some instances they were filed under the generic
“conditional approval” category.
Number of therapeutic injunctions ordered by the courts from 1992 to 1998
Departmental
Court |
1992 |
1993 |
1994 |
1995 |
1996 |
1997 |
1998 |
Bobigny |
735 |
860 |
1110 |
926 |
1406 |
990 |
304 |
Lille |
119 |
248 |
161 |
196 |
176 |
195 |
103 |
Nanterre |
- |
- |
377 |
304 |
263 |
234* |
231* |
Paris |
454 |
413 |
640 |
- |
- |
- |
- |
National |
- |
- |
7678 |
8630 |
8812 |
8052 |
4254 |
*According to data provided by the Nanterre
departmental court
Source: Annuaire
statistique de la Justice 2000
In examining the data on
people who appeared at convocation hearings — this is not to be confused with
measures ordered — it is also apparent that the number of people smoking
hashish is very high in comparison with the number of heroine users: in 1991 the
gap was 49% (cannabis) to 6.3% (heroine); it balanced out in 1992 (45% to 44%),
increased in 1993 (59% compared to 37.5%) and rose to 62.5%, compared to 34% in
1994. In the same year, the Nanterre departmental court ordered 87% of all
therapeutic injunctions for heroine, 6% of those for cannabis and 6% of those
for cocaine.
This example illustrates
the significant differences in criminal policies regarding offences under the
drug act. In Nanterre, people arrested are referred to the court for repeat
heroine use; in Bobigny, however, procedures are launched when “soft” drugs
are used, though they are socio-medical preventive measures rather than criminal
procedures. For heroine users, therapeutic injunctions are ordered immediately
on the basis of the user’s
criminal record. If he has a record of serious offences
or if a stay of execution did not include the requirement to undergo
therapy, the case is turned over to the courts for proceedings to be undertaken.
For cannabis users who are more or less on the fringe of society and going
through rough times (family conflict, on the run, drop-outs or unemployed),
therapeutic injunctions are a means of helping users return to society.
Generally, follow-up is short and easy to comply with, and success rates are
high.
3.
Inequities under the drug act
The changing attitudes in
France are reflected in the fact that smoking cannabis is no longer considered
as significant as it was, in the on-and-off debate on decriminalization, in the
trend towards distinguishing between use, abuse and addiction, regardless of the
drug (legal or illegal) involved, and in the acknowledgment of the real risks
involved. Official indicators reveal that about one out of three young people
have smoked cannabis at least once in their lives and that the number of young
people who have smoked more than ten times doubled between 1993 and 1997. A
shift in government policy therefore seems inevitable. According to Nicole
Maestracci, President of the Mission
interministérielle de lutte contre la drogue et la toxicomanie (MILDT)
(Intergovernmental Mission to Fight Drugs and Addiction): “Abstinence cannot
be the only goal of prevention any more. It is true that it is better not to
take drugs, but there is no such thing as a drug-free society.” In short, it
seems that a more pragmatic approach will follow what until now has been an
approach focused almost exclusively on legal punishment and marked by a
moralizing attitude. The issue is not to embrace drugs, nor simply to give up or
be lenient about drugs. It is to make the law credible once more, and in so
doing to apply it consistently and not arbitrarily, as has often been the case.
Yet in practice the police
arrest a great many drug users, in and around Paris as well. Courts deal
predominantly with cases originating from neighbourhoods considered sensitive
because they contain more users, and more cannabis and heroin dealers. The
increasing number of ecstasy and cocaine seizures at the border should not make
us forget that police and the courts have very little impact on places where
people actually buy and take drugs. The increasing number of raves, where young
people listen to techno music and take ecstasy (considered very cool with the
“in” crowd), are rarely patrolled by the police. We are not calling for a
sharp crackdown on raves. However, it is a simple fact that police and the
courts approach people of different social status differently. Although this is
difficult to quantify, it appears that more people in the “higher” strata of
society experiment with drugs. Almost 50% of children in wealthy families have
experimented with cannabis, while that figure is only 20% for children in
working-class families.
Therefore, people at the
margins of society and urban areas are increasingly criminalized; this
phenomenon may be compared to the process described by Wacquant (1999). It also
appears that criminalizing some drugs and tolerating others, which are just as
dangerous but are regulated by government, creates new inequities in French
society. Criminalizing the social habits of the most deprived, who are forced to
live in poor neighbourhoods, masks tolerance of illicit drug use by the rich and
exacerbates the feeling of injustice of marginalized young people.
Conclusion
How can we reconcile both
public health and law and order concerns under a single consistent and pragmatic
public policy? These are the issues underpinning the mechanisms and measures
implemented in France over the past few years. Treating illegal products, like
cannabis and heroin, and legal products, like tobacco, alcohol and medication,
equally under the law already represents a minor revolution in a country where
alcohol is a mainstay of social life, including the workplace. But there is a
great deal of resistance, politicians are often reluctant to change their
position and, in a context where drugs are increasingly associated with urban
juvenile delinquency, the stigma associated with drug use remains strong. The
government is the main actor in this area. It is addressing the problem of
illegal drug use by treating it more like a medical problem and providing drug
substitution programs. However, society’s changing attitude has little impact
on the situation and behaviour of drug users. If in marginalized urban areas
drug use and trafficking are part of some people’s lives, an ad
hoc response might be to focus on prevention programs. But though this is a
principle, it is not being considered a priority.
In day-to-day police
activities, the crackdown on illegal drugs in “sensitive” neighbourhoods and
towns is only partially effective, both for internal reasons (lack of
co-ordination, the effects of competition and limited resources) and external
reasons (the layout of a place, and well-organized dealers and trafficking,
among other things). Dealers have therefore developed a strategy of setting up
drug houses in outlying areas, while the police have focused on cracking down in
downtown areas. The limited effectiveness of public authorities may be veiling a
deeper crisis, a crisis in which the fundamental approach has ceased to work.
How can a user be released just hours after being arrested on the street? How
credible is legislation that makes it nearly impossible to move cannabis and
heroin users along within the system? If the problem is one of application,
amending the legislation will have no effect: changing the law will not
necessarily change the way it is applied by the courts.
Michel Kokoreff
Université de Lille 1,
Clersé-Césames (NSRC)
Bibliography
Aubusson de Cavarlay B.
(1997), L’usage de stupéfiants dans les filières pénales, Psychotropes, 4, pp. 7-24.
Barré M.D., (1996). Toxicomanie et délinquance.
Relations et artefacts, Déviance et société,
20, 4.
Barré M.-D., (2001).
Drogues, délinquance et mise en cause policières, Questions
pénales, XIV, June.
Beck F., Peretti-Watel P.
(1999), EROOP 99. Enquêtes sur les représentations,
opinions et perceptions relatives aux psychotropes, OFDT.
Bergeron H.,(1999), L’Etat
et la toxicomanie. Histoire d’une singularité française, Paris, PUF.
Bernat de Célis J., (1992)
“Fallait-il créer un délit d’usage illicite de stupéfiants ? Une étude
de sociologie législative,” Déviance
et contrôle social, Paris, Cesdip.
Cesoni M., (2000) L’incrimination de l’usage de stupéfiants dans sept législations européennes, GDR document, Psychotropes, politique et société, No. 4.
Comité consultatif
national d’éthique pour les sciences de la vie et la santé (1994), Rapport sur les toxicomanies, No.
43, Paris.
Commission sociale de
l’Episcopat (1997), Eglise et société.
Médecins, éducateurs, politiques, associations s’expriment, Paris,
Centurion/Cerf.
Coppel A., (1996).
Toxicomanie, sida et réduction des risques, in Communications
No. 62.
De Munck J., (1996), La
consommation de drogues dans le conflits de normes, in Communications
No. 62.
Drogues
et droits de l’homme, LDH Dossiers & documents, No. 29, May-June
1996.
Duprez, D, Kokoreff, M, (2000) Les
mondes de la drogue. Usages et trafics
dans les quartiers, Paris, Odile Jacob.
Duprez D., Kokoreff M., Weinberger M., (1996) Le
Traitement institutionnel des affaires liées à l’usage de drogues, Lille,
Paris, IFRESI-GRASS.
Duprez D., Kokoreff M., Weinberger
M. (2001), Carrières, territoires et filières
pénales. Pour une sociologie comparée des trafics de drogues (Hauts-de-Seine,
Nord, Seine-Saint-Denis), Paris, OFDT.
Ehrenberg A., (1995). L’individu
incertain, Paris, Calmann-Lévy.
Ehrenberg A., (1996).
Comment vivre avec les drogues ? in Communications
No. 62,
Emmanuelli J., (1997),
Usages de drogues, sexualité,
transmission des virus VIH, VHB, VHC et réduction des risques en prison à
travers le monde : état des lieux et mise en perspective, revue de littérature,
Institut de Veille Sanitaire (ex-RNSP).
Emmanuelli J., (1999), Caractéristiques
et efficacité des programmes d'échange de seringues à travers le monde :
états des lieux et mise en perspectives, literuature review, October,
Institut de Veille Sanitaire.
Emmanuelli J., (2001).
Programmes d’échange de seringues et réduction des risuqes chez les usagers
de drogues dans le monde développé : état des lieux et perspectives, Paris,
Document du Césames, No. 8.
Fassin D., (1998) Les
figures urbaines de la santé publique. Enquête sur des expériences locales,
Paris, Éditions La Découverte.
Garapon A., (1996). Justice
et drogue, in Communications No. 62.
Henrion R. (1995), Rapport
de la commission de réflexion sur la drogue et la toxicomanie, Paris, La
documentation française.
Joubert M. (1999),
Politiques locales et nouveaux dispositifs dans le domaine des toxicomanies, Déviance
et Société, vol. 23, No. 2,
pp. 165-187.
Kokoreff
M., (2000). Faire du business dans les quartiers,
Déviance et société,, Vol 24, No. 4.
Kokoreff M., (2001).
L’incertitude des politiques pénales. L’exemple du contentieux des stupéfiants,
Clés, Lille.
Lert F. (2000). Situation des traitements de substitution en France en 1999,
Document préparé pour le rapport 2000 de l’OFDT à l’EMCDDA, non publié.
Morel A., (1997). Les
intervenants en toxicomanie et la loi de 1970, Psychotropes,
vol 3, No. 4.
Morel A. (2001),
Traitements de substitution à la buprénorphine : l’expérience française,
MILDT, site de la MILDT.
MILDT (1999), Plan triennal de lutte contre la drogue et de prévention des dépendances,
Paris, MILDT, collection “Savoir plus, risquer moins ».
OFDT (1999), Drogues et toxicomanies. Indicateurs et tendances, Paris, OFDT.
Perez-Diaz
C., (1989). Les disparités des politiques
pénales de répression de l’usage et du trafic de stupéfiants, Paris,
CESDIP.
Rencontres nationales sur
l’abus de drogues et la toxicomanie (1997), Actes
des rencontres 12-13 décembre 1997, Ministère de l’Emploi et de la
Solidarité, Secrétariat d’Etat à la santé.
Setbon M., (1995). Drogue, facteur de délinquance ?
D’une image à son usage, Revue française
de science politique, 45, 5.
Setbon M., (1998).
L’injonction thérapeutique. Evaluation du dispositif de prise en charge
sanitaire des usagers de drogues interpellés, Cachan,CNRS-GAPP.
Simmat-Durand L. (dir.)
(1998), L’usager de stupéfiants entre répression
et soins : la mise en œuvre de la Loi de 1970, Paris, CESDIP.
Simmat-Durant L., (2001) La lutte
contre la toxicomanie. De la législation à la réglementation, Paris,
L’Harmattan.
Wacquant L., (1999). Les prisons de la misère, Raison d’agir, Le Seuil.
[1]
For an overview of the situation in France, see Faugeron and Kokoreff (to be
published, 2002).
[2]
See
the drug act and drug policies of European countries like Italy,
Switzerland, the Netherlands and some German cities like Frankfurt, which
are moving towards decriminalizing some types of use and developing public
health policy (Cesoni, 2000). Even Sweden, which to date has been extremely
inflexible about prohibiting all drug use, is beginning to thaw. Note the
role played by EMCDDA as a forum for concerted action.
[3]
Some persuasive statistics: at present, FF 4.5 billion, (approximately 30 billion
euro) are invested in repressing drug use, while only FF 700 million (4.6
billion euro) are invested in carte and prevention measures (Kopp, Palle,
1997).
[4] See the Simmat-Durant census (2001).
[5]
For example, see proponents of the null category, not defined anywhere in
the trafficking and use legislation, which as of 1971 appeared in police
statistics, as reported by C. Pérez-Diaz (1989). A series of circulars
issued until 1986 contributed to the application
of criminal treatment for the new category, by causing a shift in the
user-reseller category, turning a conviction for use into one for minor
trafficking..
[6]
On the criminalization of drug trafficking by organized gangs on a business
model, see Duprez, Kokoreff, Weinberger, 2001.
[7]
As stipulated in article 1 of the Act: “Any person using illegal
substances or plants classified as narcotics shall be placed under the
supervision of the health authorities.”
[8]
See Ehrenberg 1995 and 1996; Garapon, 1996; Coppel, 1996. The same
criticisms appear in “official” reports commissioned by the government,
the latest dating back to R. Henrion’s term (1995).
[9]
A. Coppel, “Drogues : arrêtez d’arrêter les usagers”, Libération, June 29, 1999.
[10]
For syringe exchange programs, see Emmanuelli 1997, 1999, 2000, 2001; Lert
2000; and Emmanuelli, Lert, Valenciano, 1999.
[11]
Commissioned by Simone Veil.
[12]
One of the consequences of modifying supply in this way is to make
buprenorphin widely available on the parallel market (see Tendances, Issue°15, OFDT, 2001), the change in the number of new
addicts introduced by the product, which is available everywhere, even in
detention facilities.
[13]
First-Line Action Report : proposals submitted for discussion, AFR, May
2001, page 14.
[14]
Pérez-Diaz, 1989; Aubusson de Cavarlay, 1997; Simmat-Durand, 1998.
[15]
It should also be noted that certain jurisdictions indicated the criteria
they used in deciding whether to prohibit the use of narcotics. This
demonstrates that there are shadowy areas in effective judicial practices.